Webinar Date: 01/16/2019 12:00PM central
Activity Dates: 01/16/2019 - 06/30/2024
The wait is over! After more than a decade, the American Academy of Neurology released updated practice guidelines on disease modifying therapies (DMT) in adults with multiple sclerosis (MS). During those 10 years, the number of therapies available to treat MS has grown exponentially with now more than ten FDA approved medications. Please join the Neurology community as they host Holly Rabideau, PharmD, BCPS, to present highlights from the new practice guidelines and to review therapies available to treat MS.
AAPP has invested in supporting the most popular web browsers and leveraging software that our members use daily. Beyond PDF downloads, the rest of the system is built on HTML5, a technology that most up-to-date browsers will support. To access AAPP course materials online, you will need:
AAPP web sites no longer fully support Microsoft Internet Explorer or Windows 8.1 and older. We cannot guarantee that the site will function perfectly on every device and configuration, but using the latest version of the software above will greatly improve your experience.
AAPP owns the copyright, is licensed or has received permissions for use of, or is otherwise permitted to use copyrighted materials within any CPE activity. Authors and speakers are required to obtain necessary copyright permissions for content in CPE activities. AAPP complies with copyright laws and regulations.